Procter & Gamble Hygiene and Health Care · NSE: PGHH · BSE: 500459
Q1 FY22 results · Apr–Jun 2021
Procter & Gamble Hygiene and Health Care reported revenue from operations of ₹786.59 crore (up 24.0% from Q1 FY21) and net profit of ₹48.98 crore (down 29.2% from Q1 FY21) for Q1 FY22 (Apr–Jun 2021), on a standalone basis.
| Item | Q1 FY22 | Q1 FY21 | YoY | Q4 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 786.59 | 634.53 | +24.0% | 759.66 | +3.5% |
| Other income | 5.72 | 9.55 | −40.1% | 14.75 | −61.2% |
| Total income | 792.31 | 644.08 | +23.0% | 774.41 | +2.3% |
| Profit before tax | 67.25 | 105.62 | −36.3% | 129.23 | −48.0% |
| Net profit for the period | 48.98 | 69.21 | −29.2% | 98.33 | −50.2% |
| EPS, basic (₹) | 15.09 | 21.32 | −29.2% | 30.29 | −50.2% |
| Net margin (%) | 6.2 | 10.9 | 12.9 |
Standalone
- Filed with BSE
- 26 Aug 2021, 18:52 IST
- Board meeting
- 25 Aug 2021
- Period
- 01 Apr 2021 to 30 Jun 2021
- Review status
- Audited
- Source
- XBRL filing on BSE